Encainide

CHEMBL315838 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

352.5 g/mol

LogP

4.3

Phase

4

This medication slows electrical signals in the heart to treat certain types of abnormal heart rhythms. It works by blocking sodium channels in heart muscle cells.

Moleküler Ağırlık

352,5000 g/mol

LogP

4,30

TPSA

41,60 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Cardiovascular Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1

InChI

InChI=1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25)

Molecular Formula

C22H28N2O2

HBD / HBA

1 / 3

Döndürülebilir Bağlar

6

Ağır Atomlar

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This medication slows electrical signals in the heart to treat certain types of abnormal heart rhythms. It works by blocking sodium channels in heart muscle cells.

Yes, Encainide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL315838. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 48041. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Encainide PillFYI'da

Yapı

Hızlı Veriler

Formül: C22H28N2O2

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.